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ABSTRACT  A kinetic  scheme  postulating  the  rapid  formation  of a  partially
active  acetylcholine-receptor-drug  complex  from  Xylocaine  (or  a  derivative)
and  the  active  acetylcholine-receptor  complex  can  account  for  the  effects  of
Xylocaine  and  its derivatives  at the neuromuscular junction.  Transmembrane
currents  generated  by  an  analogue  computer  programmed  according  to  the
scheme can exactly match end plate currents produced by nerve stimulation  in
the presence  of the drugs. The scheme also  accounts for the  qualitatively differ-
ent effects  of the  drugs  on  the  end plate  potential  and  on  responses  to  ionto-
phoretically  applied  acetylcholine.  The  analysis  presented  is  consistent  with
very  rapid  reactions  between  acetylcholine  and  receptors,  characterized  by
rate coefficients  in  the range  104 to  106 sec-'.  It  is based  on the  hypothesis that
the  activation  of  receptors  by  acetylcholine  changes  the  structure  of  the  re-
ceptors  and  thus  their  affinity  for  Xylocaine.  The  analysis  does  not  require
pharmacological  separability  of  sodium  and  potassium  conductances  during
the end plate current.
Procaine,  Xylocaine,  and  derivatives  of Xylocaine  depress  and  modify  the
response of the postsynaptic  receptors  of the neuromuscular junction to acetyl-
choline  (ACh)  (22,  25). The most striking aspect of the effects  of these drugs
is the production of a prolonged component of the end plate potential  (e.p.p.)
that cannot  be ascribed  to an  anticholinesterase  action.  In  this  respect,  and
in many other  details,  the actions  of the drugs  differ  greatly  from that of d-
tubocurarine  (d-TC)  and  other  chemicals  that  also  depress  the  response  of
receptors.  However,  the site of action of Xylocaine  and procaine,  like that of
d-TC, appears to be at the postsynaptic receptors  (22, 25).  This  suggests that
these drugs modify the kinetics of the receptor response,  although they do not
produce  a response  themselves.  Thus,  an analysis  of the  effects  of Xylocaine
and  procaine  at the neuromuscular junction  should offer the  opportunity to
find out more about the receptors themselves.
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Although  this  article  considers  explicitly  only  the  effects  of  Xylocaine
(lidocaine,  lignocaine)  and its  chemical  derivatives,  the  conclusions  reached
probably apply  to procaine  as well.  A  model for  the action  of procaine  has
already been proposed  (22). To formulate this model, Maeno investigated the
action of procaine  on the externally  recorded  miniature end plate potentials
(e.m.e.p.p.'s)  and the changesin the"shunting" effectof  the e.p.p.  (5)  on the
muscle action potential during treatment with the drug. These studies led to a
hypothesis that procaine depresses the increase in conductance for sodium ions
during the early phase of the e.p.p.,  and also  promotes a prolonged  residual
sodium  conductance  increase  to  produce  the  prolonged  phase.  Using  an
electrical  circuit model  for the  end  plate  membrane  with separate  time-de-
pendent  resistances to represent the suggested  separate ionic channels  for po-
tassium ions  and sodium  ions,  Maeno  found  that it was possible  to qualita-
tively reproduce the  e.p.p.'s observed  in muscle fibers  treated with procaine.
Maeno's explanation,  which will be considered  in more detail,  is based  on  a
method  of analysis quite  different from that used in the present  case.  I shall
begin  by considering  the  normal  reaction  between  ACh  and  receptors,  and
then utilize what is known of the action of d-TC as a basis for considering  the
action  of Xylocaine  on  the receptors.  The resulting  model for the action  of
Xylocaine and its derivatives  is expressed first as a scheme of chemical reactions
and then as the relevant set of differential  equations, which can be solved  by a
small analogue  computer. The output of the computer was used to generate a
transmembrane  current at the muscle  end plate, and the model was tested by
compensating or balancing  the physiological  end plate current  in chemically
treated muscles with the computer-generated  current.
MATERIALS  AND  METHODS
The  preparation,  recording  techniques,  and  drug solutions  used  were  the  same  as
described  previously (25).  In testing the kinetic  scheme,  the following  procedure was
used.  A Donner model  3500 analogue computer  was programmed to solve  the set of
differential  equations  describing the  model (Appendix  1).  A shaped  voltage pulse  at
the input of the computer (corresponding  in  time course to the pulse of ACh released
by the nerve terminal)  produced  a voltage at the output. The output of the computer
was  connected  to a  10 megohm  resistance  and  thence  to  a  second  micropipette  in-
serted  into the end plate  region  of the fiber being  studied;  thus current was injected
into  the  fiber.  The  preparation  was  treated  with  Xylocaine,  one  of its  derivatives,
d-TC or about 8 mM magnesium ion (4) until an e.p.p. of low amplitude was obtained
upon nerve stimulation. The injected current was adjusted in over-all  time course and
amplitude,  by changing  the parameters  of the computing circuit,  to balance the flow
of current produced  by the activated end plate following nerve stimulation,  and thus
to maintain the muscle fiber at resting potential  throughout the duration  of the e.p.p.
When  this  balance  was  achieved,  the  current  injected  (monitored  with  a  series
resistance,  see Fig.  1) was the end plate current. The muscle membrane  was thus used
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current.  This method cannot deal with negative  resistances,  as can  the conventional
voltage clamp using electronic feedback (28). However, it should  be noted that in the
present case the balancing current was generated  according to a scheme that could be
analyzed to determine the kinetic parameters  of the generating  process.  A block dia-
gram  showing  the  connections  between  the  computer,  the preparation,  and  the  re-
cording  devices  is  given  in  Fig.  1. The  operation  of  the  computer  is  discussed  in
Appendix  1.
THE  MODEL  KINETIC  SCHEME
In  a preceding article  (25)  the effects of Xylocaine  and its derivatives  at the
neuromuscular junction were described,  and the following three part  hypoth-
FIGURE  1.  Block  diagram  of equipment  required  for tests  of the kinetic  model.  The
muscle  fiber is shown impaled  with two micropipettes,  one connected  to the recording
amplifier and the other to the output of the computer.  The computer input comes  from
a Tektronix  161  pulse  generator.  The solid rectangle connected  to the resistance  labeled
r monitor  indicates  the  indifferent  electrode.  The  monitor  resistance  normally  had  a
value  less than  10 kohm,  and current flowthroughit  was displayed  by recording voltage
across it differentially.  Alternatively, current produced by the computer output  could be
monitored with a small resistance  (not shown)  in series with the  10 megohm resistor.
esis was  suggested.  (a)  The drugs  do not  significantly  reduce  the rate of rise
of the e.p.p.  because they do not appreciably  inhibit receptors  before the be-
ginning of the ACh-receptor  reaction.  (b)  They  reduce  and curtail the early
brief component of the e.p.p. by strongly inhibiting the ACh-receptor reaction
once  it has  begun.  (c) Some  drugs  produce  a  prolonged  component  of the
e.p.p. by promoting the continuing activity of some of the ACh-receptor com-
plex formed  during  neuromuscular  transmission.  This latter effect  is  always
preceded  by strong  inhibition,  as shown  by the  effects of pulses  of drug  ap-
plied after pulses of ACh  (25).
To evaluate this hypothesis,  it is convenient  to adopt a formal kinetic equa-
tion describing the reaction of ACh with receptors  (7-9).
I64A.  B. STEINBACH  Kinetic Model for Xylocaine Action
ACh  +  k 2 R  kACh-R(i)  ACh-R(a)




Reaction  1 states that ACh reacts reversibly  with receptors  (R) to form first
an inactive (i) and then an active  (a)  complex; it is the active complex that in
some unknown way produces a permeability  change in the postsynaptic mem-
brane,  and thus a flow of end plate current and depolarization  of the muscle
fiber  (5,  13).
Both a low temperature coefficient for the response of receptors  (17, 26) and
stoichiometric  relations between  physiological release of ACh and receptor re-
sponse  (10, 20,  21) support the reaction scheme diagrammed in reaction  1.
d-TC appears  to be a  reversible  competitive  inhibitor of receptor  response
(2,  15).  Bath  concentrations  of  d-TC  reduce  the  amplitude  of  the  e.p.p.
without  appreciably  changing  its  time  course,  probably  because  (a)  d-TC
forms  inactive  complexes  with receptors  in the  absence  of ACh  and  (b)  the
steady-state  "concentration"  of the d-TC-receptor  complex is not significantly
changed  by  the reaction  between ACh  and receptors  during neuromuscular
transmission  because  of the relatively  slow association  and dissociation  of the
d-TC-receptor  complex,  indicated  in  studies  of the  effects  of  iontophoretic
application  of d-TC  (7,  13,  25).
A simple kinetic scheme that provides  the basis of a model for the action of
Xylocaine  is given  by reaction  2 which  should  be considered  in conjunction
with reaction  1
ACH-R(a)  +  X  k--  ACh-R-X  - ACh  +  R  +  X  (2)
kT_  k-4
The stable complex ACh-R-X formed by reaction  (2)  is the essential part of
the  kinetic  model.  The symbol X  denotes  Xylocaine or one of its analogues,
and the reaction  to form ACh-R-X is assumed to be about as rapid as the re-
actions  between ACh  and receptors.  The dissociation  of the  ACh-R-X com-
plex is postulated to be comparatively slow. The ACh-R-X complex is assumed
to be partially  active  (and to produce  a prolonged  permeability  change  be-
cause of its stability) or inactive,  depending on the Xylocaine derivative used.
All  these  assumptions  follow  from  experimental  observations.  Thus,  in  the
model as written, the decrease in the early peak of the e.p.p. is due to the rapid
conversion of the ACh-R(a) complex into the less active or inactive ACh-R-X
complex,  and the prolonged  component,  if present,  results from the low level
activity  of  the stable ACh-R-X complex.  Any  decrease  in  amplitude  of the
e.p.p. resulting  from a d-TC-like  action of Xylocaine  is not incorporated  ex-
plicitly into the model  (see Discussion).
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One may  write  a  simple  equation  relating  the  normal  end  plate current
(lend  plate)  to  the concentration  of activated  receptors  (using  chemical  sym-
bols in brackets  to indicate concentration):
lend  plate  =  a[ACh  - R(a)]  (3)
where  a  is a proportionality constant.
Equation  (3)  is  a  valid approximation  only for end  plate currents  of low
amplitude.  If Xylocaine  is  present  in  the  solution  bathing  the  preparation,
some ACh-R-X complex  will  be  formed during application  of ACh,  and the
end  plate  current  will depend on  the  concentration  of this complex  as well.
In  this case
lend plate  =  a[ACh  - R(a)] +  ax[ACh  - R  - X]  (4)
In  equation  (4)  ax is  also  a proportionality  constant.  The ratio ax/a is  de-
fined  as  the relative  activity  of  the  ACh-R-X complex.  For  convenience  in
later computations a was set equal to 1, so that ax/a  = ax .
The concentration  of Xylocaine  (X) is constant throughout a given experi-
mental test of the model (considering bath application only), because the vol-
ume  of the synaptic space is small compared with the total volume of solution
(3),  and because there appear to be no effective barriers to diffusion into this
space  (7,  16).
To  simplify  the  differential  equations  describing  the  model,  the  effective
concentration  of receptors  (R)  will  be  assumed  to  remain  constant  during
transmission.  Waser  (30)  has estimated that fewer  than  10%  of the ACh re-
ceptors  in the rat diaphragm  are activated during transmission.  Saturation of
receptor  responses,  which would  occur  if the  number  of receptors  available
during transmission were  not large,  is not normally observed  (14).  In the rat
diaphragm,  iontophoretically  applied  pulses  of ACh  (calculated  to produce
peak  concentrations  of zero to 2  X  10-6 M ACh near  the receptors)  produce
up to  10 mv potential changes and no sign of saturation  (20).
The postulate that the ACh-R-X complex is very stable leads to the assump-
tion  that the  value  of the  rate  coefficient  k_3  is  small relative  to other  rate
coefficients.  As a simplification,  k- 4 was  also assumed to be  negligibly small;
the justification for this will come from the experimental  tests of the model.
It  is convenient  to lump all the reactions  leading to the formation of ACh-
R(a) into a single reversible  reaction,  and thus to write the active  complex as
ACh-R henceforth. The error introduced  by this approximation  is slight,  and
primarily affects  the very early rising phase of the e.p.p.
In a form that can be tested,  the kinetic  scheme  appears  as below in reac-
tions 5  and 6
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f(rel)
I  k  +  ACh-R  (5j
A  h  R  '  k-1
kd 
AC-R  +  X  · ACh-R-X  ACh  +  R  +  X  (6)
k-3 k-4
The value of kd,  a first-order rate coefficient,  is determined by the processes
of diffusion  and hydrolysis  of ACh  by AChE.  The notation f(rel)  is  used to
indicate  the processes  that provide  ACh to the reaction  scheme  (e.g.,  release
by the nerve or from a pipette).
Working from reactions  (5)  and  (6) and incorporating the assumptions dis-
cussed, it is possible to describe the kinetic scheme  in terms of a set of differen-
tial equations whose  solutions  can be programmed on  an electronic  analogue
computer  (see  Methods).  The objectives  of the  tests using the computer  as a
source of transmembrane  current  were  (a)  to determine  whether  the kinetic
scheme was adequate to describe the action of Xylocaine  (that is,  to determine
whether  the  computer-generated  current  would  balance  all  end  plate  cur-
rents)  and if so,  (b)  to determine the values of the parameters involved in the
scheme.  The differential  equations and the equations describing  the operation
of the computer circuits are given in Appendix  1. The pertinent effective rate
coefficients  in the kinetic  scheme are: kR, k_l,  k3X,  k 4 , and kd  (dimension:
sec-),  and  these  can  be  shown  to  correspond  in a  one-to-one  fashion  with
values  of parameters  in  the  computing  circuit.  The  relative  activity  of the
ACh-R-X complex  (ax) was adjustable  from 0 to 1. In  all tests reported here,
k1R was set equal to  104 sec-' and  k_L  = 5  X  103 sec- 1 . Values of k 4 from 5 to
40 sec-  were  used and values  of k3X from 0 to  104 sec-.  The value assigned to
kd was 5  X  103 sec - ' (see Appendix).  Balance was defined  as the nulling of at
least  70%  of the  physiological  e.p.p.  The optimal  values  of each parameter
necessary  for  balance  could  be determined  within  the  following  ranges  (de-
termined by trial and error); k4 0.1  sec-', ax  0.01, kX was determined
to within  10%.
RESULTS
Figs.  2 and 3  illustrate  typical experimental  tests of the model.  During treat-
ment with chemicals such as  14465 or QX-222  (25) the end plate current con-
sisted  of an  initial  transient  of brief  duration  and  a  prolonged  component
(Fig.  2 d). The initial transient was always briefer than the end  plate current
during  treatment  with d-TC  or high  magnesium  (Fig.  2 F).  The same early
brief component  characteristic  of the  effects  of all  Xylocaine  derivatives  is
seen  in  Fig.  3  (A-C),  recorded  during  treatment  with  Xylocaine,  but  the
current monitor at the sensitivity used does not clearly show the low amplitude
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FIGURE  2.  Use  of the  muscle  membrane  as a  null detector  to  directly  compare  the
output  of  the  computer  model  and  the  physiological  end-plate  current.  The figures
are photographic  composites,  recorded  from two fibers.  Upper, during treatment with
about 1.8 m  chemical  14465,  (a)  =  physiological end plate potential;  (b)  =  artificial
end plate potential produced  by the  current shown  in  (d);  (c)  resultant of computer-
generated  and  physiological  currents  together,  illustrating  the  balance  that  may  be
obtained.  Calibration  pulse,  I  msec,  1 my; current calibration  4  X  10-9  amp. Lower,
during treatment with about 0.01  mm d-TC, (D) two traces of potential evoked by nerve
stimulation with the simultaneous injection  of computer-generated  current shown in (F)
and  one  trace  without  current  injection.  Calibration  pulse,  1 msec,  I  my;  current
calibration 6  X  10-9 amp. Note the difference  in time scale  in lower and upper figures.
prolonged component  of the  injected  current.  In  this  test,  during  treatment
with d-TC or high magnesium ion,  k 3X  and oax were 0, whereas during  treat-
ment with Xylocaine, k3X was 5  X  103 sec-1 and ax was 0.05.  In  seven experi-
ments,  each involving  tests with  at least two Xylocaine  derivatives and d-TC
or high  magnesium  ion, it was  always  possible  to balance  physiological  end
plate currents with  the previously stated fixed values of k1R and  k_l and with
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FIGURE 3.  Experiment similar to that shown in Fig.  2  using EDL IV,  resting potential
-82 my. Each trace consists  of three or more responses  photographically superimposed.
A-C,  preparation  treated  with 0.35 mM  Xylocaine.  A, physiological  e.p.p.,  trace below
A monitors current and  shows only the nerve stimulus  artifact.  C,  artificial  e.p.p.  pro-
duced by current shown in trace below  B, in the absence of nerve stimulation.  B,  balance
achieved  with  injected  and  physiological  currents  applied  together,  trace  below  B
showing both injected  current and  nerve stimulus  artifact.  D-F,  similar experiment  in
the  same preparation  treated  with  8.0  mM  magnesium  ion.  Quantal  variations  of the
response led  to the negative-going  trace  in E. The  injected  current is  shown in F. Note
that the current  is  of long duration  compared  with the  large early phase of that in the
trace below  B.  Calibration pulses 1 my, 1 msec; current calibration bars, 5  X  10- 9 amp.
2mv
10 -8 A
FIGURE  4.  Tracings  of artificial end  plate potentials  (upper  traces)  produced  by com-
puter-generated  currents  (lower  traces)  applied  across the membrane  of EDL IV in the
absence of nerve stimulation  and chemical  treatment. The  falling phases  of most wave-
forms  have  been  omitted  for  clarity.  The parameter  kX was  increased  from  0  to  104
with  tax  =  0 to produce the series.
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FIGuRE  5.  Comparison  of responses  of EDL  IV fiber  to computer-generated  currents
and  to  nerve stimulation  in  the presence  of Xylocaine  or  one  of its  analogues.  A,  re-
sponses  to  computer-generated  currents; kX  =  5  X  10s sec-1,  k4 =  40  sec- ,  ax as
indicated. C, same preparation, k3X  = 5  X  108 sec-1, k4 = 7 sec -1except  for dotted  line
trace, produced  by reducing f(rel) in amplitude  and setting kX  = 0 to simulate  effects
of d-TC. The value of ax indicated  as 0.06 was probably misread,  and ought to be about
0.03.  B,  responses  of a  different  fiber  to nerve  stimulation  in the  presence  of various
chemicals  (as noted; dotted  trace,  response  in the presence  of d-TC, 0.005  nm).  Please
note the difference  in time scale in A and C and in B.
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a fixed time course  off(rel), making  changes only in kaX, k4, and ax . In any
one experiment,  the  optimal value of k3 was constant. The value of ax varied
from  an  extreme  of 0  (in  the  case  of treatment  with QX-314  and  similar
chemicals)  to about 0.3  (during treatment with chemicals  14465 or QX-222).
[Analysis  of  Fig.  2(a-d)  shows  that  currents  that  decline  continuously
(monotonically)  after  an early  transient  can produce  potential changes  that
have a minimum  between the early transient  and the prolonged component.
This somewhat surprising relation  between  current and potential change  re-
flects  the  normal  complexity  of  skeletal  muscle  structure,  and  can  be  ac-
counted for by the electrically  equivalent model for muscle membrane intro-
duced by Falk and Fatt (12,  24).  Xylocaine and  its derivatives do not affect
the passive impedance  of muscle at the concentrations used here, and the same
relations  are  found  in  chemically  untreated  muscles  stimulated  by  applied
current  (Fig. 6).]
FIGURE  6.  Response  of  EDL
IV  fiber  to  a  series  of  trans-
membrane computer-generated
currents in the absence of nerve
stimulation  or  chemical  treat-
ment.  The  potentials  (upper
traces)  were  produced  by  in-
creasing  ax  with  kX  set  to
5  X  103  sec-l; the  increase  in
the  prolonged  component  of
current  as  a  result  is  clearly
seen  in the  lower  traces.  Cali-
brations, 2mv, I msec,  1 X  I0 9
amp. Reprinted  from Nature (Stein-
bach, A.  B.  1967.  216:1331).
One can  obtain a good qualitative picture  of the capabilities of the kinetic
scheme  by examining  the  potential  changes produced  in  muscle  fibers  by  a
series of injected currents in the absence of drug treatment or nerve stimulation
(Figs. 4-6). In these cases, positive current  was passed outwards through the
membrane.
With  ax set  to zero,  the output of the  model  was  changed  by increasing
kX from 0 to  104 sec-1. This change produced a decrease in amplitude and an
increased  rate  of early  fall  of the output,  with no significant  change  in  the
absolute rate of rise of either the output or the response of the muscle (Fig. 4).
At the maximum value of ksX, the peak amplitude of the potential change was
about 25% of its initial amplitude.
An increase  in ax for a fixed value of kaX increased  the amplitude  of the
prolonged component of current and of potential (Figs. 5 and 6). Fig. 5 shows
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that  the  range  of potential  changes  produced  covers  the  range  of e.p.p.'s
produced  by treatment  with Xylocaine  derivatives.  Also, comparison  of Fig.
5 A and 5  C shows that the  time to prolonged peak and  the duration  of the
prolonged component depend on the value of k 4.
When long inputs  (corresponding  to the  pulses of ACh released iontopho-
retically from a pipette)  were used with the computer,  the output,  as a func-
tion of kX and ax (Fig. 7),  was qualitatively different from the output of the
computer in response  to a brief pulse simulating  the release of ACh from the
nerve  terminal.  For ax  =  0,  increasing  k3X decreases  the  amplitude  of the
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FIGURE  7.  Responses  of the muscle  fiber  (EDL  IV)  to  computer-generated  currents
(lower  traces)  in the case  of a long input pulse to the  computer. These responses  were
intended to  simulate  the response  of the muscle  end  plate to iontophoretically  applied
pulses  of ACh.  a, a', response  of the muscle (upper  trace)  to current (lower  trace)  with
k3X  =  0 and ax  =  0.  b,  b', response  when  kaY  =  5  X  103  sec
-'  and ax  = 0. c, c',
response with same values of k3X but ax  = 0.01.  The tracings shown in this figure should
be compared  with those  of Fig.  8 in reference  25.
response and does not greatly change its time course.  For 0  <  ax  <  0.01,  in-
creasing k3X produces a decrease in amplitude, and an increase in the time to
peak  and  over-all  duration  of the  response  (see  reference  25,  Fig.  8).  For
larger  values  of ax,  the  response  is  increased  in amplitude  and  prolonged.
This computer simulation applies  only to effects on  iontophoretically  evoked
responses during the bath application of drugs.
DISCUSSION
Using the computer programmed  according  to the scheme,  one can produce
currents that are the equal of end plate currents evoked  by nerve stimulation
during treatment with Xylocaine and its derivatives. This was shown by direct
tests of the model using the muscle membrane as a null detector. Qualitatively,
the same model can reproduce  the range of effects of Xylocaine derivatives on
the  response  to  iontophoretically  applied  ACh.  It  is  now  clear  that  while
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Xylocaine derivatives appear  to have different effects on the e.p.p. and on the
iontophoretically  evoked response  (25)  because  of the different  durations  of
the ACh pulses involved,  in fact  the basic  action of the chemicals in the  two
cases  may well  be the same.  Considering  the results  of all  tests,  it  is appro-
priate to discuss  the values of the parameters of the kinetic scheme and their
meaning.
The estimated value range of ax,  based on tests involving the e.p.p., was 0
to 0.3.  If the  model included  all actions of Xylocaine and its derivatives,  the
computer output with ax set to 0.3 should quantitatively duplicate  the effects
of  the  Xylocaine  derivatives  14465  and  QX-222  on  the  iontophoretically
evoked response.  Experimentally,  values of ax in excess of 0.01  (roughly that
characterizing  Xylocaine)  did  not  produce  such  quantitative  agreement;
that is, they produced an increase in the response amplitude, which was rarely
seen physiologically  (25).
This discrepancy  might be the result of a purely inhibitory d-TC-like  ac-
tion of the  drugs at the relatively  high concentrations  used  in testing  effects
on the  iontophoretically  evoked response.  If the  drugs  do have  some d-TC-
like  activity,  which  is  quite  possible  in  view  of  their  molecular  structures,
the  estimate  of ax obtained  from  studies of the  e.p.p.  is probably the  more
correct one.  However,  an error in the value of k1R  (and thus in the values  of
k_l  and  k3X,  see  following  discussion)  might  also  produce  an  error  in  the
determination  of ax.  If the  rate  coefficients  governing  the  forward  reac-
tions  between  ACh  and  R,  and  ACh-R  and  X  were  underestimated,  the
range of values of aYx determined would have been overestimated. This would
not greatly affect the response of the model to simulated brief pulses  of ACh,
but would  become  evident  in  tests  with longer  pulses,  when  the  formation
of ACh-R-X goes on for a longer time.
In the scheme  tested,  the value  of kIR was  104 sec-'. Lower  values did not
suffice but the value actually used was simply the maximum value permitted
by the computer  for real-time  operation.  Therefore,  although  kR  must  be
at least  104 sec-1,  it might be larger. To obtain  an estimate  of the maximum
value,  consider  that  the scheme  must  be capable  of reproducing  the  effects
of Xylocaine  on  the early component  of the e.p.p.,  and  that these  effects are
not observed when the input to the computer  was made about  10 to 100 times
as long as the  pulse  designed to simulate  the release  of ACh from  the nerve
(compare  the durations  of computer outputs  in Figs.  4 and  7).  Thus,  within
the context of the model,  it appears  that kjR  could not be more  than  10-100
times the value actually tested;  i.e.,  not greater than  10-106 sec-.  The value
of k_, was  set,  relative  to  klR,  to optimize the computer output.
In order  to produce  the  characteristic  effects  of Xylocaine  on the  e.p.p.,
the value  of k3X must  be allowed  to attain  a value  at least  as  large  as  k_,
If it were  not,  the  conversion  of ACH-R  to ACh-R-X would  not take  place
I73THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  · VOLUME  52  I968
to a significant  extent.  However,  k3X need  be  no larger than klR; if it were,
the rate  of  rise  of the  e.p.p.  would  be  significantly  reduced.  The  value  of
k3X  used  in  tests  was  between  5  and  10  X  103  sec-',  and  the  exact  value
depended  in  each  case  on  the  concentration  of  Xylocaine  or  derivative  in
the  solution  bathing  the  preparation  (normally  0.2-1.5  mM).
It would  be  desirable  to  compare  the  response  of the  model  to a  steady
input  and  the  response  of the  end plate  to  a  steady  concentration  of ACh
in  the  presence  of Xylocaine.  However,  ACh  in  steady concentrations  pro-
duces  desensitization  of  the  receptors  (18,  23),  and  incorporation  of  this
phenomenon  would  have  made  the  model  unjustifiably  complex.  Because
the  tests of the model  involved only responses  to transient  inputs,  R,  the ef-
fective  concentration  of receptors,  cannot  be  calculated  from  kR  and  k_1
although  reasonable  estimates  of the value of the dissociation constant  of the
ACh-R complex  (Kd  =  k_l/kl) might be  made.
For any  given  muscle preparation  tested,  the  value  of k4 did  not have  to
be  adjusted  during  the  successive  applications  of several  Xylocaine  deriva-
tives.  This  suggests  that  the  stability  of the  ACh-R-X  complex  is about  the
same  regardless  of the  Xylocaine  derivative  involved.  In  the  seven  prepa-
rations  examined,  the  optimum value  of k 4 varied  from about 5  to 20  sec-'.
This low  range  validates  one  of the  original  postulates  of the  scheme;  that
the  ACh-R-X  complex  must  be  relatively  stable  in  order  to  produce  the
prolonged current.  It  also appears  that the  assumption  that k_4  is negligible
is justified,  although  such  a  back  reaction  to form ACh-R-X would  be very
difficult  to detect,  due  to the  rapid  removal  of the transmitter  by diffusion
and hydrolysis.  The variation in k 4 from preparation  to preparation  is similar
to the variation in other effects of the chemicals that can be observed directly
(25)  and may well reflect a variation in the properties of receptor populations.
The  actions  of Xylocaine  and  its  derivatives,  and  also  of  procaine  (22)
are  clearly  more  complex  than  the  action  of d-TC  (25).  According  to  the
hypothesis  presented  here,  this  difference  can  be  attributed  to  two  main
differences  in the level of molecular interactions  between  drug and receptors.
(a)  d-TC has a high affinity for receptors and forms complexes  with receptors
in  the  absence  of ACh  (7,  15).  Xylocaine  and  its  derivatives  have  a  low
affinity for receptors  in  the  absence  of ACh,  but have  a  high  affinity for  at
least  some  receptors  after  the  receptors  have  been  activated  by  ACh.  (b)
The  d-TC-receptor  complex  is  relatively  stable  but  completely  inactive.
The complex formed when Xylocaine  (or a derivative) reacts with a receptor
after it has been activated by ACh  is also stable, but may  have  some activity
(less  than  0.3  that  of the  ACh-R  complex)  depending  upon  the  structure
of the drug  used.
In  formulating  the  kinetic  model,  it  was  assumed  that  the  increase  in
membrane  ionic  permeability  producing  the  end plate  current  is  relatively
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nonselective  (5,  27,  29).  This implicit  assumption  created  no  difficulties  in
tests  of the model;  that is,  it was  not necessary  to consider the possibility  of
ion-selective  changes  in permeability  during  receptor activation  in the pres-
ence  of the  drugs  tested,  including  procaine.  Maeno  (22)  deduced  that  a
selective  decrease  in  AgNa  (the  increase  in conductance  for the  sodium  ion
FIGURE  8.  Effect of a  change  in  membrane  potential  (produced  by passing  a steady
current  through  the second  micropipette)  on the time course of the e.p.p.  in EDL  IV
during  treatment  with  chemical  14465.  Electrical  excitability  and  contraction  were
eliminated  by  allowing  the  negative  capacity  amplifier  connected  to  the  recording
microelectrode  to  oscillate--this treatment  did  not alter  the  e.p.p.  The  tracings  have
been brought to a common base line to permit visual comparison;  the numbers indicate
the  membrane  potential  before stimulation.  The anomalous  effect  of hyperpolarization
(from -60 my to -92  my)  also occurs  for potentials  evoked  by  injected  currents,  and
can  be attributed to changes  in the impedance  of the muscle membrane that occur with
hyperpolarization  (1). There is no indication that the reversal potential for the prolonged
component  is different from that of the early component  (see text).
produced  by receptor activation)  occurred  during the early brief component
of the  e.p.p.  during  treatment  with procaine,  and  that this  was  superseded
by  a  prolonged  residual  sodium  current  during  the  prolonged  component.
From this conclusion one would expect  that the reversal  potentials of the two
phases  (early  and  prolonged)  of the  e.p.p.  during  treatment  with  procaine
(or  Xylocaine)  would  be  different.  However,  in  slightly damaged  prepara-
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tions where it was possible to shift the muscle fiber membrane potential beyond
zero,  the  entire  e.p.p.  reversed  at  -5  to  -15 mv  during  treatment  with
procaine  or  Xylocaine  derivatives  (Fig.  8).  Although  such  tests  might  not
have  revealed  slight  changes  in  the  reversal  potential  of  the  early  com-
ponent  of the  e.p.p.,  they strongly suggest  that the  prolonged  component  of
the end plate  current  is not carried  by sodium  ions  alone.
Thus it was not possible  to confirm  that the action  of Xylocaine and pro-
caine  involves  any  selective  effect  on  receptors  that  might  control  mem-
brane  permeability  for  only  one  ion.  The  complex  change  in  the  e.p.p.
produced  by  Xylocaine  derivatives  (and  to  a  lesser  degree,  by  procaine)
can  be  understood  in  terms  of relatively  simple  changes  in  the  end  plate
current  provided  that  adequate  account  is  taken  of  the  complexity  of the
passive  impedance  of  muscle  membrane  (12,  24).  The  equivalent  circuit
used by Maeno  (22)  was not adequate in this respect, since the muscle mem-
brane  was represented  only  by  a  resistance  in  parallel  with  a  capacitance.
The nature of the  proposed ACh-R-X complex cannot  be determined  un-
ambiguously  from the kinetic scheme  presented.  Perhaps the most reasonable
hypothesis  is  that ACh  and  X are  bound  to  separate  sites  on the  same  or
adjacent  molecules  in such a manner,  that binding  to one site influences  the
properties  of  the  other.  Both  of these  sites  are  ACh receptor  sites,  but  the
binding of ACh to one changes the specificity  of the other so that its  affinity
for  Xylocaine  is  greatly  increased.  The  stability  of  the  resulting  complex
might result from the presence of the terminal ring in Xylocaine; preliminary
results  indicate  that  Xylocaine  derivatives  lacking  the  ring  do  not  pro-
duce  prolongations  of the  e.p.p.  and have  little effect  on  the  time  course  of
the  early  brief component.  But although  a detailed molecular  model cannot
be  constructed  from  the  present  data,  one  postulate  for  the  construction  of
such  a  model  is  strongly  suggested,  namely,  that  the  effects  of  Xylocaine
occur  because  of changes  in  receptor  structure  produced  by  the  action  of
ACh.  Such change in receptor structure  might reasonably be  involved in the
transduction  of chemical  binding  to  membrane  ionic  permeability  change.
APPENDIX  1
Implementation of the Kinetic Scheme
A Donner model 3500 electronic analogue computer  was used  to solve the differential
equations  describing  the kinetic scheme. The mode of operation of such computers  is
discussed  in standard  textbooks,  e.g. (19).  Referring  to the diagram of circuit  I below,
consider the triangle labeled (2). The triangle denotes a high open-loop gain inverting
amplifier.  Imagine  that  the  only  components  connected  around  the  amplifier  are
R4, C1, and R2. VACh  is the voltage at the  input, and  VACh-R  that at  the output. The
amplifier keeps the voltage at the input node (marked  with a solid circle) at essentially
ground  potential, and by applying Kirchoff's laws  to that node (imagining that  only
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the components  mentioned  are present),  one obtains the following input-out relation:
1:1  dVAch-R/dt  =  (-  1/R 2C)  VAch  - (/R 4C1) VAh-R
The configuration  considered  above is  the  basic configuration  used in the circuit
that implements  the kinetic  model.  In presenting  this circuit,  I shall  first write down
the  kinetic  scheme  and the  circuit  used  to  implement  it,  and  then  the differential
equations describing  the scheme  and the nodal equations  of the circuit.
Equations 5 and 6 (text)  Circuit 1
f(rel)
I  k
ACh +  R  5ke  ACh-R
,/  k-l 
kd  Vf  (re
ACh-R  +X  k3  ACh-R-X
k-3




dtAChJ  f(rel)  +  k-[ACh-R]
dt
- kR[ACh]  - kd[ACh]
+  *(k4[ACh-R-X[
- k-4[ACh[R][X
1:2v (for node 1)
dVACh  _  Vf(rel)  _  ACh-  _  VACh  _  VACh  Circuit  1; see Appendix for discussion.
dt  RIC 1 R4C 1 R2C 1 R6C,
1:3
d[ACh-R] =  kR[ACh]  - k-,[ACh-R] - kX[ACh-R]  +  *(k-3[ACh-R-X])
dt
1:3v (for  node  2)
dVAch-R  VACh  VACh-R  XgVACh-R
dt  R2C 1 R4C1 R9C 1
1:4
d[ACh-R-X] d[AChRX] =  k3X[ACh-R]  - k4[ACh-R-X]
dt
+- *(k-4[AChI[R[X]  - kACh-R-X])
*  Because  of simplifications discussed  in the text, the terms preceded by an asterisk were neglected in
the computations  made with the computer.
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1:4v (for node 5)
dVx-R  _  xgVACh-R  VX-R
dt  R7C 2 RsC 2
1:5
d[R] -d]  =  0 by assumption. R  is not represented  by a voltage but is included
in the effective  rate coefficient,  k1R.
1:6
d[X] =  0 by assumption. X is  not represented  by a voltage but is included
in the  effective rate coefficient,  k3X.
All the relevant parameters  of the kinetic equations correspond  to values  of resis-
tances and capacitances  in the  nodal equations,  as summarized  below:
Parameter  Corresponding  value in computer
f(rel)  Vf(.ol)/R
[ACh]  - VACh
[ACh-R]  - VACh--R
[ACh-R-X]  - VX-R
klR  I  /R2C1
k-,  1  /R4C
kd  1  /R6C1
k3X  xg/R gC  = xg/R7C 2
k4  1  /R8C2
[0  <  X  <  1, set by adjusting Rx; g  = (Ru/Rio)(Ri3/R2)]
It  is  necessary  to  satisfy  the  output  relationship  of equation  5  in  the  text.  The
voltage divider Rax(where  0  <  ax <  1) was used in order to establish a variable rela-
tive  activity  for  the  various  Xylocaine  derivatives.  When  an inverting  amplifier  of
unity gain was used to reverse the sign of VX-R,  the two voltages  VAch-R  and ( Vx-R)ax
were  summed  by another  inverting  amplifier  of unity  gain  to  produce  the  output,
Vout.  Thus:
(5)  (from text)
Iend pla
te  = a[ACh-R]  +  ax[ACh-R-X]
1:7
- Vout  =  VACH-  +  ax( V-R)
It  happens that for a  positive  Vf(l) the output is a  negative  voltage.  As discussed
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in the text, a is assumed to be unity; thus the correspondence  between voltage  in the
model  and concentration in  the kinetic scheme is one-to-one.  The voltage  Vf(rl) was
formed  by  filtering  a  brief  pulse  from  a  Tektronix  161  pulse  generator  through  a
variable  network  of resistors  and  capacitors,  and  was  adjusted  empirically  to corre-
spond to the suspected  time course off(rel). This was estimated from previous studies
(11,  6), taking into account the known time course of the end plate current (28)  and
estimates  of rates of diffusion  of ACh  liberated from the terminal  (11).  The values of
components governing kd were chosen to produce a time course of  VAch-R  correspond-
ing to the experimentally  determined  end plate current (see reference  28).
Note Added  in Proof A recent  paper  (Gage,  P.  W.,  and  C.  M.  Armstrong.  1968.
Nature. 218:363)  studies the change in the duration of the miniature end plate current
as a function of membrane potential  and suggests that ACh opens separate  channels
for potassium  and for sodium ions. The effect studied might also result  from a direct
effect  of membrane potential  on the time course  of activation  of a nonion-selective  re-
ceptor.  Changes  in the light scattering  and  birefringence  of nerve cell membranes  as
a result  of changes in membrane potential have  recently  been demonstrated  (Cohn,
L.  B.,  R.  D. Keynes,  and  B.  Hille.  1968.  Nature. 218:438).
Receivedfor publication 12 December 1967.
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